Pathogen inactivation of whole blood and red cell components: An overview of concept, design, developments, criteria of acceptability and storage lesion

Transfusion and Apheresis Science

Volumn 49, Issue 2, 2013, Pages 357-363

  Seghatchian, Jerard ^a   Putter, Jeffrey S ^b  

^a International Consultancy in Blood Components Technology   (United Kingdom)

^b Medical Biomechanics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMUSTALINE; OXYGEN;

ARTICLE; BACTERIUM CONTAMINATION; BLOOD COMPONENT; BLOOD SAFETY; BLOOD STORAGE; BLOOD TRANSFUSION; CLINICAL PRACTICE; ERYTHROCYTE; ERYTHROCYTE PRESERVATION; HUMAN; PATIENT CARE; PATIENT SAFETY; PRION; THROMBOCYTE TRANSFUSION; VIRUS INACTIVATION;

BLOOD PRESERVATION; BLOOD SAFETY; DISINFECTION; ERYTHROCYTES; FRANCE; HUMANS;

EID: 84886641989     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2013.07.023     Document Type: Article

References (0)